Consolidated industry network created
Monday, 05 March, 2001
BioMed North is a consolidated network of research institutions, hospitals, industry and investors collaborating with the ultimate aim of improving health outcomes in the community. The major participating institutions are: Australian Institute of Musculo-Skeletal Research; Australian Government Analytical Laboratories; Australian Proteome Analysis Facility; CSIRO Molecular Science, Riverside; Institute for Bone & Joint Research; Institute for Magnetic Resonance Research; Kolling Medical Research Insttitute; Macquarie University; Northern Clinical School; Northern Diabetes Centre; Pacific Laboratory Medicine Services; Pain Management & Research Centre; Royal North Shore Hospital & Northern Sydney Area Health Service; Southern Cross University; Sydney Medical Simulation Centre; and University of Technology, Sydney.
The strength of this alliance lies in the partnership and centralisation of the combined wealth of academic, medical, basic research, biotechnology and business resources in the northern corridor of Sydney and affiliated regions. Access to the expertise of the Australian Biotechnology Association is assured.
Consequently, this alliance will ultimately provide a tangible benefit to participating groups and result in enhanced investment, expansion and productivity in all areas of biomedical and biotechnological research within the network.
Further enquiries should be directed to: Professor Carol Pollock ph 9926 7126
AXT to distribute NT-MDT atomic force microscopes
Scientific equipment supplier AXT has announced a partnership with atomic force microscope (AFM)...
Epigenetic patterns differentiate triple-negative breast cancers
Australian researchers have identified a new method that could help tell the difference between...
Combined effect of pollutants studied in the Arctic
Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine...